Screener
Veradermics MANE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Veradermics’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
FAQ
- What is Veradermics's total equity?
- Veradermics (MANE) reported total equity of $390.64M in Q1 2026.
- How has Veradermics's total equity changed year-over-year?
- Veradermics's total equity increased by 743.9% year-over-year, from -$60.67M to $390.64M.
- What is the long-term trend for Veradermics's total equity?
- Over 2 years (2023 to 2025), Veradermics's total equity has grown at a 133.3% compound annual growth rate (CAGR), from -$22.24M to -$121.01M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Veradermics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude